Commercial Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool BioPharma DiveSome 1,390 Foundayo prescriptions were written in two days, according to analysts.CommercialMetabolic & GLP-1Read full story pharminent April 17, 2026 (Last updated: April 17, 2026) BioPharma Dive Some 1,390 Foundayo prescriptions were written in two days, according to analysts. CommercialMetabolic & GLP-1Read full story Post navigation Previous: Lilly’s Foundayo reaches 1,390 patients in first week, trailing Novo’s oral Wegovy launchNext: Kailera makes history with record-breaking $625m IPO Related Stories Commercial Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand pharminent September 14, 2026 Commercial Lilly’s $23B Q2 soars over expectations but Foundayo lags Novo’s rival oral GLP-1 pharminent August 5, 2026 Commercial Leqembi sales grow again after subcutaneous approvals pharminent July 29, 2026